Anti-HRK monoclonal antibody

Pre-made anti-HRK monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to HRK/HRK products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP0981-Ab-1/ GM-Tg-hg-IP0981-Ab-2Anti-Human HRK monoclonal antibodyHuman
GM-Tg-rg-IP0981-Ab-1/ GM-Tg-rg-IP0981-Ab-2Anti-Rat HRK monoclonal antibodyRat
GM-Tg-mg-IP0981-Ab-1/ GM-Tg-mg-IP0981-Ab-2Anti-Mouse HRK monoclonal antibodyMouse
GM-Tg-cynog-IP0981-Ab-1/ GM-Tg-cynog-IP0981-Ab-2Anti-Cynomolgus/ Rhesus macaque HRK monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP0981-Ab-1/ GM-Tg-felg-IP0981-Ab-2Anti-Feline HRK monoclonal antibodyFeline
GM-Tg-cang-IP0981-Ab-1/ GM-Tg-cang-IP0981-Ab-2Anti-Canine HRK monoclonal antibodyCanine
GM-Tg-bovg-IP0981-Ab-1/ GM-Tg-bovg-IP0981-Ab-2Anti-Bovine HRK monoclonal antibodyBovine
GM-Tg-equg-IP0981-Ab-1/ GM-Tg-equg-IP0981-Ab-2Anti-Equine HRK monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP0981-Ab-1/ GM-Tg-hg-IP0981-Ab-2; GM-Tg-rg-IP0981-Ab-1/ GM-Tg-rg-IP0981-Ab-2;
GM-Tg-mg-IP0981-Ab-1/ GM-Tg-mg-IP0981-Ab-2; GM-Tg-cynog-IP0981-Ab-1/ GM-Tg-cynog-IP0981-Ab-2;
GM-Tg-felg-IP0981-Ab-1/ GM-Tg-felg-IP0981-Ab-2; GM-Tg-cang-IP0981-Ab-1/ GM-Tg-cang-IP0981-Ab-2;
GM-Tg-bovg-IP0981-Ab-1/ GM-Tg-bovg-IP0981-Ab-2; GM-Tg-equg-IP0981-Ab-1/ GM-Tg-equg-IP0981-Ab-2
Products NameAnti-HRK monoclonal antibody
Formatmab
Target NameHRK
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-HRK monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP0981-Ag-1Recombinant multi-species HRK/ DP5/ HARAKIRI protein
    ORF Viral VectorpGMLP001870human HRK Lentivirus plasmid
    ORF Viral VectorvGMLP001870human HRK Lentivirus particle
    ORF Viral VectorpGMLPm004507mouse Hrk Lentivirus plasmid
    ORF Viral VectorvGMLPm004507mouse Hrk Lentivirus particle


    Target information

    Target IDGM-IP0981
    Target NameHRK
    Gene ID8739,12123,117271,107001036,612984,109493221,787139,100629981
    Gene Symbol and SynonymsBid3,DP5,HARAKIRI,HRK
    Uniprot AccessionO00198,P62817
    Uniprot Entry NameHRK_HUMAN,HRK_RAT
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000135116
    Target ClassificationN/A

    The target: HRK, gene name: HRK, also named as DP5, HARAKIRI. This gene encodes a member of the BCL-2 protein family. Members of this family are involved in activating or inhibiting apoptosis. The encoded protein localizes to intracellular membranes. This protein promotes apoptosis by interacting with the apoptotic inhibitors BCL-2 and BCL-X(L) via its BH3 domain. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Oct 2012].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.